Evidence map›Paper›PMID 38619491›Full record

Observational studyAddiction biology2024

Substance use patterns, quantities, and associated risk factors in women with polysubstance misuse.

Nia Fogelman, Marshall Tate, Stephanie Wemm, Liam Sullivan, Rachel Hart, Erin Vacey, Helen C Fox, Rajita Sinha

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Addiction biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
4.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nia FogelmanYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-0156-7220
Marshall TateYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Stephanie WemmYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-8754-7479
Liam SullivanYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Rachel HartYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Erin VaceyDepartment of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA.
Helen C FoxDepartment of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA.ORCID 0000-0002-3607-439X
Rajita SinhaYale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-3012-4349
Yale University · USStony Brook School · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Guanfacine Target Engagement and Validation to Improve Substance Use Outcomes in WomenR01DA047094 · NIDA · YALE UNIVERSITY · PI SINHA, RAJITA · 2019 to 2021
$2.4M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS R01 DA047094NIDA NIH HHS R01-DA047094
6 · The paper itself

Abstract

Polysubstance use (PSU), the use of two or more substances proximally, is highly prevalent and has amplified the risk for morbidity and mortality. However, PSU patterns and associated risk factors are not well characterized. This may be especially relevant to women who are known to be vulnerable to stress/trauma, craving, pain, and anxious and depressive symptoms as associated risk factors for PSU. A cross-sectional observational study was conducted to characterize substance use patterns in women who regularly used cocaine, opioids, marijuana, alcohol, benzodiazepines and/or nicotine and were being assessed for a placebo-controlled study of guanfacine treatment (n = 94; ages 19-65). Data on stress/traumatic life events, drug cravings for each substance, pain ratings, and anxiety and depressive symptoms were also obtained using standardized well-validated surveys. High use per day of two or more drugs was observed (72.7% ± 33.3%) and opioid amounts were high relative to other drug amounts (p's < 0.001). Notably, higher stress/trauma events and higher cravings are each associated with cumulative PSU days, amounts and probability of an individual PSU day (p's < 0.02). This remained when PSU versus single substance use was compared. Pain, anxiety and depressive symptoms were not associated with PSU metrics. These findings characterize specific patterns of PSU in women and show that average drug craving and stress/trauma events are associated with PSU. Interventions that focus on stress/trauma and craving management could be of benefit in reducing PSU risk in women.

Indexed as

AnxietySubstance-Related DisordersAnalgesics, OpioidCross-Sectional StudiesFemaleHumansPainRisk FactorsAnalgesics, Opioiddrug cravingpolysubstance usestress/traumawomen

Identifiers

PMID38619491
PMCPMC11017971
OpenAlexW4394820079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.